Surgical management of metastatic bone disease

Journal of Bone and Joint Surgery

Volumn 91, Issue 6, 2009, Pages 1503-1516

  Bickels, Jacob ^a   Dadia, Shlomo ^a   Lidar, Zvi ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM; MEDRONATE TECHNETIUM TC 99M;

ACETABULUM; BONE DESTRUCTION; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FECES INCONTINENCE; FRACTURE; FUNCTIONAL ASSESSMENT; HEMIPELVECTOMY; HUMAN; HYPERCALCEMIA; INTRACTABLE PAIN; INTRAMEDULLARY NAILING; JOINT PROSTHESIS; KIDNEY METASTASIS; KYPHOPLASTY; LONG BONE; LUNG METASTASIS; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OUTCOME ASSESSMENT; PATHOLOGIC FRACTURE; PERCUTANEOUS VERTEBROPLASTY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; REVIEW; SOFT TISSUE; SPINAL CORD METASTASIS; SPINE; SPINE INSTABILITY; SPINE METASTASIS; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR SEEDING; URINE INCONTINENCE; WALKING DIFFICULTY; WEIGHT BEARING; BONE TUMOR; CANCER STAGING; FEMALE; MALE; METASTASIS; METHODOLOGY; MORTALITY; OSTEOSYNTHESIS; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT SELECTION; RADIOGRAPHY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

BONE NEOPLASMS; FEMALE; FRACTURE FIXATION, INTERNAL; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURES, SPONTANEOUS; HUMANS; MALE; NEOPLASM STAGING; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; PATIENT SELECTION; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67649881911     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.H.00175     Document Type: Review

References (136)

1. Manoso MW, Healey JH. Metastatic cancer to the bone. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer. Principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. p 2368-2380
2. Dorfman HD. Metastatic tumors in bone. In: Dorfman HD, Czerniak B, editors. Bone tumors. St. Louis: Mosby; 1998. p 1009-1040
3. Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Clin Orthop North Am. 2000;31:515-28, vii.
4. Bauer HCF. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br. 2005;87:608-617 (Pubitemid 40716035)
5. Geschickter CF, Maseritz IH. Skeletal metastasis in cancer. J Bone Joint Surg Am. 1939;21:314-322
6. Toma CD, Dominkus M, Nedelcu T, Abdolvahab F, Assadian O, Krepler P, Kotz R. Metastatic bone disease: a 36-year single centre trend-analysis of patients admitted to a tertiary orthopaedic surgical department. J Surg Oncol. 2007;96:404-410 (Pubitemid 47519446)
7. Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655-1664
8. Schulman KL, Kohles J. Economic burden of metastatic bone disease in the U.S. Cancer. 2007;109:2334-2342 (Pubitemid 46801565)
9. Franzius C, Schuck A, Bielack SS. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol. 2002;20:1953-1954 (Pubitemid 34273292)
10. Houston SJ, Rubens RD. The systemic treatment of bone metastases. Clin Orthop Relat Res. 1995;312:95-104.
11. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer. 1997;80(8 Suppl):1628-1645 (Pubitemid 27444035)
12. Thurman SA, Ramakrishna NR, DeWeese TL. Radiation therapy for the treatment of locally advanced and metastatic prostate cancer. Hematol Oncol Clin North Am. 2001;15:423-443 (Pubitemid 32762166)
13. Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'Reilly SE, Olivotto IA. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;110:973-979
14. Ryan CJ, Elkin EP, Cowan J, Carroll PR. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation. Cancer. 2007;110:81-86 (Pubitemid 46986421)
15. Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, Eiermann W, Wolter JM, Azab M, Webster A, Plourde PV. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol. 1996;14:2000-2011 (Pubitemid 26230100)
16. Kaufmann M, Bajetta E, Dirix LY, Fein LE, Jones SE, Zilembo N, Dugardyn JL, Nasurdi C, Mennel RG, Cervek J, Fowst C, Polli A, di Salle E, Arkhipov A, Piscitelli G, Miller LL, Massimini G. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol. 2000;18:1399-1411 (Pubitemid 30205385)
17. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783-792 (Pubitemid 32222155)
18. O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, Fumoleau P, Jones S, Lui WY, Mauriac L, Twelves C, Van Hazel G, Verma S, Leonard R. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol. 2002;20:2812-2823 (Pubitemid 34651510)
19. Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med. 1998;339:357-363 (Pubitemid 28363797)
20. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer. 2000;88:1082-1090 (Pubitemid 30127670)
21. Lipton A, Cook R, Saad F, Major P, Garnero P, Terpos E, Brown JE, Coleman RE. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer. 2008;113:193-201. (Pubitemid 351976401)
22. Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman JJ. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial - the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003;21:3150-3157 (Pubitemid 46606297)
23. Coleman RE. Risks and benefits of bisphosphonates. Br J Cancer. 2008;98:1736-1740
24. Jadu F, Lee L, Pharoah M, Reece D, Wang L. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol. 2007;18:2015-2019 (Pubitemid 350286242)
25. Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol. 2006;24:16-24. (Pubitemid 46630489)
26. Gainor BJ, Buchert P. Fracture healing in metastatic bone disease. Clin Orthop Relat Res. 1983;178:297-302.
27. Bickels J, Kollender Y, Wittig JC, Meller I, Malawer MM. Function after resection of humeral metastases: analysis of 59 consecutive patients. Clin Orthop Relat Res. 2005;437:201-208 (Pubitemid 41099089)
28. Harrington KD. Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect. 1986;35:357-381
29. Kollender Y, Bickels J, Price WM, Kellar KL, Chen J, Merimsky O, Meller I, Malawer MM. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol. 2000;164:1505-1508 (Pubitemid 30781689)
30. de la Monte SM, Moore GW, Hutchins GM. Metastatic behavior of prostate cancer. Cluster analysis of patterns with respect to estrogen treatment. Cancer. 1986;58:985-993
31. Toyoda Y, Shinohara N, Harabayashi T, Abe T, Akino T, Sazawa A, Nonomura K. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol. 2007;52:163-168 (Pubitemid 46802996)
32. Scheid V, Buzdar AU, Smith TL, Hortobagyi GN. Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer. 1986;58:2589-2593 (Pubitemid 17232912)
33. Sherry MM, Greco FA, Johnson DH, Hainsworth JD. Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favorable prognosis. Cancer. 1986;58:178-182
34. Bremner RA, Jelliffe AM. The management of pathological fracture of the major long bones from metastatic cancer. J Bone Joint Surg Br. 1958;40:652-659
35. Harrington KD, Johnston JO, Turner RH, Green DL. The use of methylmethacrylate as an adjunct in the internal fixation of malignant neoplastic fractures. J Bone Joint Surg Am. 1972;54:1665-1676
36. Wedin R, Bauer HCF, Wersäll P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res. 1999;358:128-139 (Pubitemid 29066082)
37. Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res. 1990;251:213-219
38. Esther RJ, Bos GD. Management of metastatic disease of other bones. Orthop Clin North Am. 2000;31:647-59, ix.
39. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab. 1991;73:1309-1315 (Pubitemid 121000708)
40. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s-9s.
41. Costa L, Demers LM, Gouveia-Oliveira A, Schaller J, Costa EB, de Moura MC, Lipton A. Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol. 2002;20:850-856 (Pubitemid 34111395)
42. Tamada T, Sone T, Tomomitsu T, Jo Y, Tanaka H, Fukunaga M. Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab. 2001;19:45-51. (Pubitemid 32048197)
43. Yang YJ, Damron TA. Comparison of needle core biopsy and fine needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med. 2004;128:759-764
44. Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am. 1981;63:653-664 (Pubitemid 11090626)
45. Althausen P, Althausen A, Jennings LC, Mankin HJ. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer. 1997;80:1103-1109 (Pubitemid 27427610)
46. Koizumi M, Yoshimoto M, Kasumi F, Ogata E. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol. 2003;14:1234-1240 (Pubitemid 37039049)
47. Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res. 2008;466:729-736
48. Fuchs B, Trousdale RT, Rock MG. Solitary bone metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop Relat Res. 2005;431:187-192 (Pubitemid 40194235)
49. Bauer HC. Posterior decompression with stabilization for spinal metastases. Analysis of sixty-seven consecutive patients. J Bone Joint Surg Am. 1997;79:514-522
50. Harrington KD. Metastatic disease of the spine. J Bone Joint Surg Am. 1986;68:1110-1115
51. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26:298-306.
52. Weigel B, Maghsudi M, Neumann C, Kretschmer R, Müller FJ, Nerlich M. Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine. 1999;24:2240-2246
53. Sundaresan N, Rothman A, Manhart K, Kelliher K. Surgery for solitary metastases of the spine: rationale and results of treatment. Spine. 2002;27:1802-1806 (Pubitemid 34894378)
54. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655
55. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;3:187-193
56. Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007;89:1794-1801 (Pubitemid 47229888)
57. Hansen BH, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalén A, Wedin R. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl. 2004;75:11-15
58. Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072-6082 (Pubitemid 46300225)
59. Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D. Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res. 2003;415 Suppl:S230-44.
60. Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110:1860-1867 (Pubitemid 47557312)
61. Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M, Torta M, Porpiglia F, Fontana D, Angeli A. Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol. 2000;164:1248-1253 (Pubitemid 30703545)
62. Brown JE, Thomson CS, Ellis SP, Gutcher SA, Purohit OP, Coleman RE. Bone resorption predicts for skeletal complications in metastatic bone disease. Br J Cancer. 2003;89:2031-2037
63. Phillips CD, Pope TL Jr, Jones JE, Keats TE, MacMillan RH 3rd. Nontraumatic avulsion of the lesser trochanter: a pathognomonic sign of metastatic disease? Skeletal Radiol. 1988;17:106-110
64. Bertin KC, Horstman J, Coleman SS. Isolated fracture of the lesser trochanter in adults: an initial manifestation of metastatic malignant disease. J Bone Joint Surg Am. 1984;66:770-773 (Pubitemid 14082344)
65. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256-264
66. Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Critical evaluation of Mirels' rating system for impending pathologic fractures. Clin Orthop Relat Res. 2003;415 Suppl:S201-7.
67. Damron TA, Ward WG. Risk of pathologic fracture: assessment. Clin Orthop Relat Res. 2003;415 Suppl:S208-11.
68. Fidler M. Prophylactic internal fixation of secondary neoplastic deposits in long bones. Br Med J. 1973;1:341-343
69. Denis F. The three column spine and its significance in the classification of acute thoracolumbar spine injuries. Spine. 1983;8:817-831 (Pubitemid 14151412)
70. DeWald RL, Bridwell KH, Prodromas C, Rodts MF. Reconstructive spinal surgery as palliation for metastatic malignancies of the spine. Spine. 1985;10:21-26 (Pubitemid 15143524)
71. Kem MB, Malone DG, Benzel EC. Evaluation and surgical management of thoracic and lumbar instability. Contemp Neurosurg. 1996;18:1-8.
72. Kostuik JP, Errico TJ, Gleason TF, Errico CC. Spinal stabilization of vertebral column tumors. Spine. 1988;13:250-256 (Pubitemid 18160857)
73. Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz LT. Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine. 1999;24:1943-1951 (Pubitemid 29449314)
74. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643-648 (Pubitemid 41176016)
75. Vena VE, Hsu J, Rosier RN, O'Keefe RJ. Pelvic reconstruction for severe periacetabular metastatic disease. Clin Orthop Relat Res. 1999;362:171-180 (Pubitemid 29226779)
76. Baloch KG, Grimer RJ, Carter SR, Tillman RM. Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br. 2000;82:62-67
77. Jung ST, Ghert MA, Harrelson JM, Scully SP. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res. 2003;409:223-231 (Pubitemid 36417733)
78. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451-1456 (Pubitemid 47463058)
79. Stojadinovic A, Shoup M, Ghossein RA, Nissan A, Brennan MF, Shah JP, Shaha AR. The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery. 2002;131:636-643 (Pubitemid 34666765)
80. van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol. 1999;35:197-203. (Pubitemid 29108145)
81. Frassica FJ, Frassica DA. Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res. 2003;415 Suppl:S212-8.
82. Kay PR. Cement augmentation of pathological fracture fixation. J Bone Joint Surg Br. 1989;71:702.
83. Kunec JR, Lewis RJ. Closed intramedullary rodding of pathologic fractures with supplemental cement. Clin Orthop Relat Res. 1984;188:183-186
84. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Grönemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300-306 (Pubitemid 41095095)
85. Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am. 2000;82:642-651 (Pubitemid 30307866)
86. Roscoe MW, McBroom RJ, St Louis E, Grossman H, Perrin R. Preoperative embolization in the treatment of osseous metastases from renal cell carcinoma. Clin Orthop Relat Res. 1989;238:302-307 (Pubitemid 19044814)
87. Bashore CJ, Temple HT. Management of metastatic lesions of the humerus. Orthop Clin North Am. 2000;31:597-609.
88. Brumback RJ, Toal TR Jr, Murphy-Zane MS, Novak VP, Belkoff SM. Immediate weight-bearing after treatment of a comminuted fracture of the femoral shaft with a statically locked intramedullary nail. J Bone Joint Surg Am. 1999;81:1538-1544
89. Hardy DC, Descamps PY, Krallis P, Fabeck L, Smets P, Bertens CL, Delince PE. Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients. J Bone Joint Surg Am. 1998;80:618-630 (Pubitemid 28237600)
90. Malawer MM, Buch RG, Thompson WE, Sugarbaker PH. Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer. J Surg Oncol. 1991;47:121-130
91. Merimsky O, Kollender Y, Inbar M, Lev-Chelouche D, Gutman M, Issakov J, Mazeh D, Shabat S, Bickels J, Meller I. Is forequarter amputation justified for palliation of intractable cancer symptoms? Oncology. 2001;60:55-59
92. Wittig JC, Bickels J, Kollender Y, Kellar-Graney KL, Meller I, Malawer MM. Palliative forequarter amputation for metastatic carcinoma to the shoulder girdle region: indications, preoperative evaluation, surgical technique, and results. J Surg Oncol. 2001;77:105-114 (Pubitemid 32520771)
93. Rose PS, Halasy M, Trousdale RT, Hanssen AD, Sim FH, Berry DJ, Lewallen DG. Preliminary results of tantalum acetabular components for THA after pelvic radiation. Clin Orthop Relat Res. 2006;453:195-198 (Pubitemid 44900983)
94. Aboulafia AJ, Buch R, Mathews J, Li W, Malawer MM. Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors. Clin Orthop Relat Res. 1995;314:203-213
95. Patterson FR, Peabody TD. Operative management of metastases to the pelvis and acetabulum. Orthop Clin North Am. 2000;31:623-631
96. Walker RH. Pelvic reconstruction/total hip arthroplasty for metastatic acetabular insufficiency. Clin Orthop Relat Res. 1993;294:170-175
97. McAfee PC, Zdeblick TA. Tumors of the thoracic and lumbar spine: surgical treatment via the anterior approach. J Spinal Disord. 1989;2:145-154 (Pubitemid 19230888)
98. Siegal T, Siegal T. Current considerations in the management of neoplastic spinal cord compression. Spine. 1989;14:223-228 (Pubitemid 19059696)
99. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990;15:1110-1113
100. Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F, Aimard T, Saillant G. Vertebral metastases: a critical appreciation of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine. 1997;22:2293-2298 (Pubitemid 28074061)
101. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30:2186-2191 (Pubitemid 41429199)
102. Ulmar B, Naumann U, Catalkaya S, Muche R, Cakir B, Schmidt R, Reichel H, Huch K. Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol. 2007;14:998-1004. (Pubitemid 46175352)
103. Findlay GF. Adverse effects of the management of malignant spinal cord compression. J Neurol Neurosurg Psychiatry. 1984;47:761-768 (Pubitemid 14059363)
104. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg. 1980;53:741-748
105. Byrne TN. Spinal cord compression from epidural metastases. N Engl J Med. 1992;327:614-619
106. Greenberg HS, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol. 1980;8:361-366
107. Martenson JA Jr, Evans RG, Lie MR, Ilstrup DM, Dinapoli RP, Ebersold MJ, Earle JD. Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC). J Neurooncol. 1985;3:77-84.
108. Chen YJ, Chang GC, Chen HT, Yang TY, Kuo BI, Hsu HC, Yang HW, Lee TS. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine. 2007;32:E413-8.
109. Falicov A, Fisher CG, Sparkes J, Boyd MC, Wing PC, Dvorak MF. Impact of surgical intervention on quality of life in patients with spinal metastases. Spine. 2006;31:2849-2856 (Pubitemid 44772788)
110. Holman PJ, Suki D, McCutcheon I, Wolinsky JP, Rhines LD, Gokaslan ZL. Surgical management of metastatic disease of the lumbar spine: experience with 139 patients. J Neurosurg Spine. 2005;2:550-563
111. Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB Jr, Wildrick DM, Swisher SG, Abi-Said D, Sawaya R. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg. 1998;89:599-609. (Pubitemid 28440929)
112. Hall DJ, Webb JK. Anterior plate fixation in spine tumor surgery. Indications, technique, and results. Spine. 1991;16 (3 Suppl):S80-3.
113. Graham AW 3rd, Mac Millan M, Fessler RG. Lateral extracavitary approach to the thoracic and thoracolumbar spine. Orthopedics. 1997;20:605-610
114. Alvarez L, Pérez-Higueras A, Quiñones D, Calvo E, Rossi RE. Vertebroplasty in the treatment of vertebral tumors: postprocedural outcome and quality of life. Eur Spine J. 2003;12:356-360 (Pubitemid 37108405)
115. Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, Ahrar K, Rhines LD, Gokaslan ZL. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg. 2003;98(1 Suppl):21-30. (Pubitemid 36050479)
116. Hadjipavlou AG, Tzermiadianos MN, Katonis PG, Szpalski M. Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures and osteolytic tumours. J Bone Joint Surg Br. 2005;87:1595-1604 (Pubitemid 43009722)
117. Singh K, Samartzis D, Vaccaro AR, Andersson GBJ, An HS, Heller JG. Current concepts in the management of metastatic spinal disease. The role of minimally-invasive approaches. J Bone Joint Surg Br. 2006;88:434-442
118. Pflugmacher R, Beth P, Schroeder RJ, Schaser KD, Melcher I. Balloon kyphoplasty for the treatment of pathological fractures in the thoracic and lumbar spine caused by metastasis: one-year follow-up. Acta Radiol. 2007;48:89-95. (Pubitemid 46324041)
119. Frassica DA. General principles of external beam radiation therapy for skeletal metastases. Clin Orthop Relat Res. 2003;415 Suppl:S158-64.
120. Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31:43-49
121. Sundaresan N, Digiacinto GV, Hughes JE, Cafferty M, Vallejo A. Treatment of neoplastic spinal cord compression: results of a prospective study. Neurosurgery. 1991;29:645-650
122. Chan D, Carter SR, Grimer RJ, Sneath RS. Endoprosthetic replacement for bony metastases. Ann R Coll Surg Engl. 1992;74:13-18
123. Eckardt JJ, Kabo JM, Kelly CM, Ward WG Sr, Cannon CP. Endoprosthetic reconstructions for bone metastases. Clin Orthop Relat Res. 2003;415 Suppl:S254-62.
124. Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am. 1980;62:954-959 (Pubitemid 10055667)
125. Selek H, Basxarir K, Yildiz Y, Saǧlik Y. Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur. J Arthroplasty. 2008;23:112-117 (Pubitemid 350299735)
126. Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87:1653-1657
127. Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996;5:508-516 (Pubitemid 26382286)
128. Enneking WF, Dunham W, Gebhardt MC, Malawer M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241-246 (Pubitemid 23059493)
129. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998;51:903-912 (Pubitemid 28527145)
130. Algan SM, Horowitz SM. Surgical treatment of pathologic hip lesions in patients with metastatic disease. Clin Orthop Relat Res. 1996;332:223-231 (Pubitemid 26372873)
131. Atesok K, Liebergall M, Sucher E, Temper M, Mosheiff R, Peyser A. Treatment of pathological humeral shaft fractures with unreamed humeral nail. Ann Surg Oncol. 2007;14:1493-1498 (Pubitemid 46536818)
132. Behr JT, Dobozi WR, Badrinath K. The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly. Clin Orthop Relat Res. 1985;198:173-178 (Pubitemid 16248259)
133. Manoso MW, Frassica DA, Lietman ES, Frassica FJ. Proximal femoral replacement for metastatic bone disease. Orthopedics. 2007;30:384-388 (Pubitemid 46860774)
134. Samsani SR, Panikkar V, Venu KM, Georgiannos D, Calthorpe D. Breast cancer bone metastasis in femur: surgical considerations and reconstruction with Long Gamma Nail. Eur J Surg Oncol. 2004;30:993-997 (Pubitemid 39462532)
135. Talbot M, Turcotte RE, Isler M, Normandin D, Iannuzzi D, Downer P. Function and health status in surgically treated bone metastases. Clin Orthop Relat Res. 2005;438:215-220 (Pubitemid 41254340)
136. Van Geffen E, Wobbes T, Veth RP, Gelderman WA. Operative management of impending pathological fractures: a critical analysis of therapy. J Surg Oncol. 1997;64:190-194 (Pubitemid 27157406)